The chances of long-term health effects because of exposure to styrene vapour, which leaked from a chemical plant in Andhra Pradesh's Visakhapatnam, are less and illnesses caused by the gas is not universally fatal, AIIMS Director Dr Randeep Guleria said on Thursday.
As far as treatment is concerned, there is no specific antidote or a definite medicine for reversing the effect of this compound. The therapy remains mainly supportive, he said.
Eleven people have died and 1,000 others exposed to styrene vapour that leaked from a chemical plant in Visakhapatnam in the early hours of Thursday and quickly spread to villages in a five-kilometre radius.
A large number of people have been admitted to hospital. Most of them are in a stable condition and hopefully will make a good recovery, Dr Guleria told reporters here.
To a question on wheather the impact of the exposure can be long-term as was in Bhopal gas tragedy, Dr Guleria said, "The gas doesn't stay for a very long time. The chances of long-term impact is less as the compound metabolises and leaves the body quickly."
"This is an acute exposure rather than a chronic exposure. But we will have to follow up and see.As of now, the data doesn't suggest any significant long-term effect."
Eyes need to be washed with water. Tissues or towel can used to clean the deposition in the skin, Dr Guleria said, "Individuals have to be monitored for any breathing difficulty or drowsiness because the compound can affect the lungs and the brain."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
